Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Safety of Lumason® (SonoVue®) in special populations and critically ill patients: Evidence for the safe use of Lumason® (SonoVue®), an ultrasound enhancing agent (UEA), in special patient populations is critical to enable… #cardiovascular htt

03 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.